Skip Navigation
CHS blue logo square
Home > Our Work > All Publications > 2013


Our publications keep professionals informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

Find an article or report or see all by area, author, or year:


The Influenza Vaccine Menu

Amesh A. Adalja
Date posted:
December 23, 2013
Publication type:

Biosecur Bioterror 2013;11(4):235-236

Mary Ann Liebert, Inc.
Open access
See also:

Full article available on publisher's site: HTML • PDF


During past influenza seasons, the principal quandary individuals faced was whether or not to get a flu vaccination. However, this flu season we have the additional decision of choosing among several different vaccine options. The fact that these options exist is a testament to the investments made to improve flu vaccine in the face of looming pandemics.

To better respond to influenza pandemics, vaccines have been sought that offer broader protection, can be delivered in novel ways, have greater immunogenicity, are antigen sparing (that is, contain less of the active ingredient), do not require eggs for manufacture, and harness recombinant technology. This year, for the first time, each of these advances is represented in one or more of the vaccine options.



Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.